n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Liver Dysfunction in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 17 (54.84) | 18.2507 |
| 2000's | 13 (41.94) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catalano, OA; Hahn, PF; Sahani, DV; Saini, S; Seale, MK | 1 |
| Adriaens, P; Bogaert, J; Bosmans, H; Cresens, E; Dymarkowski, S; Marchal, G; Ni, Y; Verbruggen, A; Zhang, H | 1 |
| Burkill, GJ; Healy, JC; King, LJ; Murray-Lyons, I; Scurr, ED; Vlavianos, P | 1 |
| Abo-Ramadan, U; Aronen, H; Häkkinen, AM; Halavaara, J; Markkola, A | 1 |
| de Beeck, BO; Fagertun, H; Fog, AF; Kane, P; Martí-Bonmatí, L | 1 |
| Reimer, P; Schima, W; Schneider, G | 1 |
| Ba-Ssalamah, A; Dirisamer, A; Happel, B; Kettenbach, J; Längle, F; Schima, W; Wrba, F | 1 |
| Chezmar, JL; Matteucci, T; Mitchell, DG; Outwater, EK; Rubin, DL; Saini, S | 1 |
| Earls, JP; Rofsky, NM | 1 |
| Eisenberg, PJ; Hahn, PF; Mayo-smith, WW; Saini, S; Sharma, P; Slater, GJ | 1 |
| Brown, ED; Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Warshauer, DM | 1 |
| Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Wilbur, K | 1 |
| Marchal, G; Ni, Y | 1 |
| Hahn, PF; Saini, S | 1 |
| Wang, C | 1 |
| Fischbach, R; Heindel, W; Jung, G; Klaus, H; Krahe, T; Kugel, H; Lackner, K; Walter, C | 1 |
| Alexandre, M; Caseiro-Alves, F; Coffin, CM; Diche, T; Mahfouz, A; Mathieu, D; Rahmouni, A; Vasile, N | 1 |
| Clément, O; Cuénod, CA; Frija, G; Leconte, I; Siauve, N; Vuillemin-Bodaghi, V | 1 |
| Balci, NC; Chung, JJ; Martin, DR; Semelka, RC; Wilber, K | 1 |
| Biederer, J; Blume, J; Grimm, J; Heller, M; Müller-Hülsbeck, S | 1 |
| De Cobelli, F; De Gaspari, A; Del Maschio, A | 1 |
| de Hemptinne, B; Elewaut, A; Mortelé, KJ; Praet, M; Ros, PR; Wiesner, W | 1 |
| de Groot, JC; Fernandez-Cuadrado, J; Grimm, J; König, M; Marquardt, M; Op de Beeck, B; Oudkerk, M; Song, B; Torres, CG; van Dijk, P | 1 |
| Bluemke, DA; Braga, HJ; Choti, MA; Lee, VS; Paulson, EK; Siegelman, ES | 1 |
| Eibl-Eibesfeldt, B; Hammerstingl, R; Lissner, J; Peqios, W; Schnell, B; Vogl, TJ | 1 |
| Branding, G; Hamm, B; Lissner, J; Schnell, B; Taupitz, M; Vogl, TJ; Wolf, KJ | 1 |
| Rofsky, NM; Weinreb, JC | 1 |
| Bernardino, ME; Lee, JK; Weinreb, JC; Young, SW | 1 |
| Peters, PE; Rummeny, EJ | 1 |
| Bernardino, ME; Lee, JK; Weinreb, J; Young, SW | 1 |
| Carter, EA; Matkin, C; Ratner, AV; Simpson, BB; Young, SW | 1 |
9 review(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Liver Dysfunction
| Article | Year |
|---|---|
Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis.
Topics: Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Retrospective Studies; Safety | 2003 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
[MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
Topics: Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Practice Patterns, Physicians'; Pyridoxal Phosphate | 2004 |
Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Topics: Adrenal Gland Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Edetic Acid; Female; Humans; Kidney Diseases; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Pancreatic Diseases; Pyridoxal Phosphate | 1996 |
Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
Topics: Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Edetic Acid; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate | 1997 |
Liver-specific MR imaging contrast agents.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxides; Pyridoxal Phosphate | 1998 |
Mechanisms of action of liver contrast agents: impact for clinical use.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intravenous; Iron; Kupffer Cells; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 1999 |
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 2001 |
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
7 trial(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Liver Dysfunction
| Article | Year |
|---|---|
Adrenal gland enhancement at MR imaging with Mn-DPDP.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 1995 |
Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 1996 |
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
Topics: Adenoma, Liver Cell; Adult; Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Follow-Up Studies; Humans; Hyperplasia; Image Enhancement; Injections, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Retrospective Studies | 1999 |
[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
Topics: Adenoma; Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cysts; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia; Humans; Liver; Liver Diseases; Liver Neoplasms; Liver Regeneration; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2001 |
Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.
Topics: Adult; Aged; Chi-Square Distribution; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Image Enhancement; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Pyridoxal Phosphate; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2002 |
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Female; Humans; Image Processing, Computer-Assisted; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 1992 |
15 other study(ies) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Liver Dysfunction
| Article | Year |
|---|---|
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Topics: Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2009 |
Exploring multifunctional features of necrosis avid contrast agents.
Topics: Animals; Contrast Media; Edetic Acid; Gadolinium DTPA; Half-Life; Liver Diseases; Liver Neoplasms; Mesoporphyrins; Metalloporphyrins; Myocardial Infarction; Necrosis; Organic Chemicals; Pyridoxal Phosphate; Rats; Rhabdomyosarcoma; Swine; Tissue Distribution | 2002 |
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Cholangiocarcinoma; Contrast Media; Edetic Acid; Female; Focal Nodular Hyperplasia; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate | 2002 |
MnDPDP-enhanced magnetization transfer MR imaging: implications for effective liver imaging.
Topics: Contrast Media; Edetic Acid; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Phantoms, Imaging; Pyridoxal Phosphate | 2003 |
Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
Topics: Adipose Tissue; Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Liver Diseases; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Organometallic Compounds; Pancreas; Pentetic Acid; Pyridoxal Phosphate | 1996 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Pyridoxal Phosphate; Tomography, X-Ray Computed | 1996 |
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Body Water; Brain; Carcinoid Tumor; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Dose-Response Relationship, Drug; Edetic Acid; Female; Humans; Image Enhancement; Infusions, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pyridoxal Phosphate; Safety; Sensitivity and Specificity; Time Factors | 1998 |
Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs.
Topics: Abdomen; Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pancreas; Pyridoxal Phosphate; Spleen | 1998 |
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Image Enhancement; Liver Abscess; Liver Diseases; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 2000 |
Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings.
Topics: Adult; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Gadolinium; Granuloma, Plasma Cell; Humans; Iron; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Suspensions | 2002 |
Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
Topics: Adult; Aged; Chi-Square Distribution; Contrast Media; Edetic Acid; Female; Humans; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Preoperative Care; Pyridoxal Phosphate; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2002 |
Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
Topics: Adult; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pyridoxal Phosphate | 1992 |
Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Sensitivity and Specificity | 1992 |
Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.
Topics: Contrast Media; Drug Evaluation; Edetic Acid; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate | 1991 |
MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
Topics: Animals; Chemical and Drug Induced Liver Injury; Contrast Media; Edetic Acid; Ethanol; Galactosamine; Liver; Liver Diseases; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Rabbits; Time Factors | 1989 |